Sumie Takahara is currently a Senior Director, Global Product and Market Planning at REGENXBIO where she leads commercial strategy and planning for gene therapy ophthalmology programs. Ms. Takahara has more than 15 years of ophthalmology experience spanning clinical research and development, product marketing, commercial launches, market access strategy and patient access services. Prior to joining REGENXBIO, she held numerous market access, marketing and clinical research roles across Regeneron, Thrombogenics and Allergan. Ms. Takahara’s ophthalmology experience began in 2002, where she was an ophthalmic photographer and clinical research coordinator at Bay Area Retina Associates in northern California. Ms. Takahara holds a B.A. in the History of Art from University of California, Berkeley.